期刊文献+

老年糖尿病患者止凝血变化的研究 被引量:5

Study on changes of hemostatic in old diabetics
暂未订购
导出
摘要 目的  探讨老年糖尿病患者止、凝血变化及其临床意义。  方法 分别检测老年糖尿病组和对照组止、凝血指标 ,包括血浆凝血酶 抗凝血酶Ⅲ复合物 (TAT)、血管性血友病因子抗原 (vWF :Ag)、蛋白C抗原 (PC :Ag)、蛋白S抗原 (PS :Ag)、P 选择素 (P selectin)、组织纤溶酶原激活物活性 (tPA :A)、纤溶酶原激活剂抑制剂 (PAI 1:A)及D 二聚体 (D D)。  结果  与对照组相比 ,老年糖尿病组的PC :Ag、PS :Ag和D D均显著增高 (P <0 0 5 ) ,vWF :Ag、TAT、t PA :A、PAI :A、P selectin增高更为明显 (P <0 0 1)。  结论  老年糖尿病患者止、凝血功能异常主要表现为血管内皮损伤、凝血系统激活、纤溶活性降低和血小板的激活 。 Objective To study the status of coagulation and anti coagulation in elderly diabetics for its clinical significance. Methods A series of hemostatic parameters were measured in elderly diabitics and normal controls,including thrombin antithrombin Ⅲ complex(TAT),antigen level of von Willebrand factor(vWF:Ag),P selectin,protein C and protein S antigen (PC:Ag,PS:Ag),tissue plasminogen activator(t PA:A),plasminogen activator inhibitor activity(PAI:A)and D dimer(D D). Results vWF:Ag,TAT,PC:Ag,PS:Ag,t PA:A,PAI 1:A,P selecting and D D were significantly increased ( P <0 05)in elderly diabetics,especially vWF:Ag、TAT、t PA:A、PAI:A and P selectin ( P <0 01). Conclusions There is abnormality in coagulability in patients with diabetes which is the result of the injury of vascular endothelium,the activation of platelests and hyperfibrinolysis.These changes are associated with the vascular complications of diabetes mellitus.
出处 《实用老年医学》 CAS 2000年第5期245-247,共3页 Practical Geriatrics
关键词 糖尿商 凝血 纤溶 老年人 Diabetes mellitus Coagulation FibrinolyL
  • 相关文献

参考文献10

  • 11,Gregory YHL,Gordon DOL,Ann Rumley,etal.Increase markers of thrombogenesis in chronic atrial fibrillation:effect ofwarfarin treatment.Br Heart J,1995,73(6):527
  • 22,Stehouwer CDA,Nauta JJP,Zeldenrust GC,et al.Urinary albumin excretion,cardiovaculardisease,and endothelial dysfunction in non-insulin-dependent diabetes mellitus.Lancet,1992,340(8815):319
  • 33,Shimizu H,Ohtani K,Tanaka Y,et al.Icreased plasma thrombin-antithrombin Ⅲcomplex levels in non-insulin dependent diabetic patients with albuminuria are reduced byethyl icosapentatenoate.Thromb Haemost,1995,74(5):1231
  • 45,Knobl P,Schernthaner G,Schnack C,et al.Haemostatic abnormalities persistdespite glycemic lmprovement by insulin therapy in lean type 2 diabetic patients.ThrombHaemost,1994,71(6):692
  • 56,Meloni L,Marongiu F,Josph,et al.Coagulation in chronic atrial fibrillation.Circulation,1997,96(3):1053
  • 67,Collier A,Rumley A,Rumley AG,et al.Free radical activity and hemostaticfactors in NIDDM patients with and without microalbuminuria.Diabetes,1992,41(8):909
  • 78,Nordt TK,Schneider DJ,Sobel BE.Augmentation of the synthesis of plasminogenactivator inhibitor type-1 in arterial endothelial cells by precursors of insulin:apotential risk factor vascular disease.Circulation.1994,89(1):321
  • 89,Nordt TK,Klassen KJ,Schneider DJ,et al.Augmentation of synthesis ofplasminogen activation inhibitor type-1 in arterial endothelial cells by glucose and itsimplications for local fibrinolysis.Arterioscler Thromb,1993,13(12):1822
  • 910,Gray R,Yudkin JS,Patterson D.Plasminogen activator inhibitor:a risk factorfor acute myocardial infartion in diabetic patients.Br Heart J,1993,69(3):228
  • 1011,Nomura S,Suzuki M,Katsura K,et al.Platelet-derived microparticles mayinfluence the development of atherosclerosis in diabetic mellitus.Atherosclerosis,1995,116(2):235 (2000-02-14收稿 2000-08-04修回)

同被引文献16

  • 1李卓成,李延武,阎德文.糖尿病患者HbA1c水平与肾脏微血管病变的关系[J].实用医技杂志,2004,11(09B):1803-1805. 被引量:5
  • 2石永兵 韩惠琴 刘志达 等.血浆蛋白C对老年糖尿病徽血管理病变的临床意义[J].中国核医学杂志,1999,19(2):66-66.
  • 3Metzeleer MJ, Clevers HC. Lysosomal membrance glycoprotein in platelets. Thromb Heamost, 2002,68(2) :378.
  • 4Michelson AD. Flow cytometry: A clinical test of platelet function. Blood, 1996,87 (23) :4925.
  • 5Salomaa V, Matei C, Aleksic N, et al. Cross-sectional association of soluble thrombomodulin with mild peripheral artery disease; the ARIC study. Atherosclerosis Risk in Communities. Atherosclerosis, 2001,157 (2): 309.
  • 6Califano F, Givovanniello T, Pantone P, et al. Clinical importance of thrombomodulin serum levels. Eur Rev Med Pharmacol Sci, 2000, 4(3) : 59.
  • 7Arrowsmith JE,Grocott HP,Reves JG,et al. Central nervous system complications of cardiac surgery[J]. Br J Anaesth, 2000,84(3):378-393.
  • 8Metzeleer MJ, Clevers HC. Lysosomal membrance glycoprotein in platelets [J]. Thromb Heamost, 2002, 68(2):378-392
  • 9Michelson AD. Flow cytometry:A clinical test of platelet function[J]. Blood, 1996, 87(23):4925-4936
  • 10李卓成 陈剑雄.NIDDM患者血浆ET RIA与肾功能损害关系的探讨[J].放射免疫学杂志,2001,12(3):312-315.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部